These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30320614)

  • 21. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Antiatherosclerotic Therapies.
    Libby P; Everett BM
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):538-545. PubMed ID: 30816799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
    Martínez GJ; Robertson S; Barraclough J; Xia Q; Mallat Z; Bursill C; Celermajer DS; Patel S
    J Am Heart Assoc; 2015 Aug; 4(8):e002128. PubMed ID: 26304941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.
    Ridker PM
    J Am Coll Cardiol; 2018 Dec; 72(25):3320-3331. PubMed ID: 30415883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation as a Therapeutic Target in Atherosclerosis.
    Nguyen MT; Fernando S; Schwarz N; Tan JT; Bursill CA; Psaltis PJ
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31357404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current pharmacotherapies for atherosclerotic cardiovascular diseases.
    Park JG; Oh GT
    Arch Pharm Res; 2019 Mar; 42(3):206-223. PubMed ID: 30725249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies.
    Banach M; Penson PE
    Curr Atheroscler Rep; 2021 May; 23(7):32. PubMed ID: 33970350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Colchicine in the Prevention of Cerebrovascular Ischemia.
    Tsivgoulis G; Katsanos AH; Giannopoulos G; Panagopoulou V; Jatuzis D; Lemmens R; Deftereos S; Kelly PJ
    Curr Pharm Des; 2018; 24(6):668-674. PubMed ID: 29336246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Anti-Atherosclerotic Therapies.
    Gluba-Brzózka A; Franczyk B; Rysz-Górzyńska M; Ławiński J; Rysz J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canakinumab for secondary prevention of atherosclerotic disease.
    Capodanno D; Angiolillo DJ
    Expert Opin Biol Ther; 2018 Feb; 18(2):215-220. PubMed ID: 29265905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory therapies for atherosclerosis.
    Bäck M; Hansson GK
    Nat Rev Cardiol; 2015 Apr; 12(4):199-211. PubMed ID: 25666404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K; Boura P; Dalekos GN; Garyfallos A; Karokis D; Pikazis D; Settas L; Skarantavos G; Tsitsami E; Sfikakis PP
    J Rheumatol; 2017 Jan; 44(1):102-109. PubMed ID: 28042127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A perspective on targeting inflammation and cytokine actions in atherosclerosis.
    Chan YH; Ramji DP
    Future Med Chem; 2020 Apr; 12(7):613-626. PubMed ID: 32175772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canakinumab for secondary prevention of coronary artery disease.
    Ortega-Paz L; Capodanno D; Angiolillo DJ
    Future Cardiol; 2021 May; 17(3):427-442. PubMed ID: 33533289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine.
    Andreotti F; Maggioni AP; Campeggi A; Iervolino A; Scambia G; Massetti M
    Eur Heart J Suppl; 2021 Oct; 23(Suppl E):E13-E18. PubMed ID: 34650351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting IL-1β in the Treatment of Atherosclerosis.
    Mai W; Liao Y
    Front Immunol; 2020; 11():589654. PubMed ID: 33362770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine for the treatment of coronary artery disease.
    Aimo A; Pascual-Figal DA; Barison A; Cediel G; Vicente ÁH; Saccaro LF; Emdin M; Bayes-Genis A
    Trends Cardiovasc Med; 2021 Nov; 31(8):497-504. PubMed ID: 33096241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.